ID

24686

Description

Study ID: 100478 Clinical Study ID: 100478 Study Title: Study to show non-inferiority of Tritanrix™-HepB/Hib-MenAC (+/- hepatitis B vaccine at birth) versus Tritanrix™-HepB/Hiberix™ without hepatitis B vacc. at birth for antibody response to all vaccine antigens given in healthy infants Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00290303 Sponsor: GlaxoSmithKline Phase: phase 3 Study Recruitment Status: Completed Generic Name: Combined Diphtheria, Tetanus, Whole Cell Pertussis, Hepatitis B, Haemophilus influenzae Type b Vaccine Trade Name: Tritanrix HepB/Hiberix Study Indication: Diphtheria; Haemophilus influenzae type b; Hepatitis B; Tetanus; Whole Cell Pertussis This form contains the Non-Serious Adverse Events form

Mots-clés

Versions (1)
  1. 13/08/2017 13/08/2017 -
Détendeur de droits

GlaxoSmithKline

Téléchargé le

13 août 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

GSK non-inferiority of Tritanrix Hepatitis B NSAE NCT00290303

Anglais

GSK non-inferiority of Tritanrix Hepatitis B NSAE NCT00290303

1 Formulaires  
Non-Serious Adverse Event
Description

Non-Serious Adverse Event

Alias
UMLS CUI-1
C1518404
Has any non-serious adverse events occurred within one month (minimum 30 days) post-vaccination, excluding those recorded on the Solicited Adverse Events pages?
Description

non-serious adverse event

Type de données

boolean

Alias
UMLS CUI [1]
C1518404
AE No.
Description

AE No.

Type de données

integer

Alias
UMLS CUI [1]
C0877248
Description:
Description

Description

Type de données

text

Alias
UMLS CUI [1]
C0678257
Administration Site
Description

Administration Site

Type de données

boolean

Alias
UMLS CUI [1,1]
C1515974
UMLS CUI [1,2]
C0013153
UMLS CUI [1,3]
C0042210
Non-administration site
Description

Non-administration site

Type de données

boolean

Alias
UMLS CUI [1,1]
C1515974
UMLS CUI [1,2]
C0042210
Date Started:
Description

Date Started:

Type de données

date

Alias
UMLS CUI [1]
C0011008
during immediate postvaccination period (30 minutes)
Description

immediate postvaccination

Type de données

boolean

Alias
UMLS CUI [1,1]
C0231291
UMLS CUI [1,2]
C0877248
Date Stopped:
Description

Date Stopped:

Type de données

date

Alias
UMLS CUI [1]
C0011008
Maximum Intensity:
Description

Maximum Intensity:

Type de données

integer

Alias
UMLS CUI [1]
C0518690
Is there a reasonable possibility that the AE may have been caused by the investigational product?
Description

Relationship to investigational products:

Type de données

boolean

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C0013227
UMLS CUI [1,3]
C0008972
Outcome:
Description

Outcome:

Type de données

integer

Alias
UMLS CUI [1]
C1705586
Medically attended visit:
Description

(Refer to protocol for full definition.)

Type de données

boolean

Alias
UMLS CUI [1]
C0545082
Medically attended visit. If yes please specify type
Description

Refer to protocol for full definition.

Type de données

integer

Alias
UMLS CUI [1]
C0545082
Retour au début de la page

Similar models

GSK non-inferiority of Tritanrix Hepatitis B NSAE NCT00290303

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Non-Serious Adverse Event
C1518404 (UMLS CUI-1)
non-serious adverse event
Item
Has any non-serious adverse events occurred within one month (minimum 30 days) post-vaccination, excluding those recorded on the Solicited Adverse Events pages?
boolean
C1518404 (UMLS CUI [1])
AE No.
Item
AE No.
integer
C0877248 (UMLS CUI [1])
Description
Item
Description:
text
C0678257 (UMLS CUI [1])
Administration Site
Item
Administration Site
boolean
C1515974 (UMLS CUI [1,1])
C0013153 (UMLS CUI [1,2])
C0042210 (UMLS CUI [1,3])
Non-administration site
Item
Non-administration site
boolean
C1515974 (UMLS CUI [1,1])
C0042210 (UMLS CUI [1,2])
Date Started:
Item
Date Started:
date
C0011008 (UMLS CUI [1])
immediate postvaccination
Item
during immediate postvaccination period (30 minutes)
boolean
C0231291 (UMLS CUI [1,1])
C0877248 (UMLS CUI [1,2])
Date Stopped:
Item
Date Stopped:
date
C0011008 (UMLS CUI [1])
Item
Maximum Intensity:
integer
C0518690 (UMLS CUI [1])
Maximum Intensity:
Code List
Maximum Intensity:
CL Item
Mild (1)
CL Item
Moderate (2)
CL Item
Severe (3)
Relationship to investigational products:
Item
Is there a reasonable possibility that the AE may have been caused by the investigational product?
boolean
C0877248 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
C0008972 (UMLS CUI [1,3])
Item
Outcome:
integer
C1705586 (UMLS CUI [1])
Outcome:
Code List
Outcome:
CL Item
Recovered / resolved (1)
CL Item
Recovering / resolving (2)
CL Item
Not recovered / not resolved (3)
CL Item
Recovered with sequelae / resolved with sequelae (4)
Medically attended visit:
Item
Medically attended visit:
boolean
C0545082 (UMLS CUI [1])
Item
Medically attended visit. If yes please specify type
integer
C0545082 (UMLS CUI [1])
Medically attended visit:
Code List
Medically attended visit. If yes please specify type
CL Item
Hospitalisation (1)
CL Item
Emergency Room (2)
CL Item
Medical Personnel (3)
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial